Pathophysiological mechanisms of parvovirus B19 infection

Journal of Clinical Microbiology

Volumn 47, Issue 7, 2009, Pages 2358-2359

  Noutsias, Michel ^a   Pankuweit, Sabine ^a   Maisch, Bernhard ^a  

^a UNIVERSITY HOSPITAL MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; IMMUNOGLOBULIN M; INTERFERON; T LYMPHOCYTE RECEPTOR; VIRUS ANTIBODY; VIRUS DNA;

ANTIVIRAL THERAPY; CD8+ T LYMPHOCYTE; CONGESTIVE CARDIOMYOPATHY; COXSACKIE VIRUS; DISEASE ASSOCIATION; DNA EXTRACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHEMA INFECTIOSUM; GENOTYPE; HUMAN; HUMORAL IMMUNITY; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; LETTER; MYOCARDITIS; PARVOVIRUS; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; SEROLOGY; VIREMIA; VIRUS DETECTION; VIRUS INFECTION; VIRUS LOAD; VIRUS REPLICATION;

HUMANS; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN;

PARVOVIRUS;

EID: 67650092747     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.00580-09     Document Type: Letter

References (15)

1. Caforio, A. L., F. Calabrese, A. Angelini, F. Tona, A. Vinci, S. Bottaro, A. Ramondo, E. Carturan, S. Iliceto, G. Thiene, and L. Daliento. 2007. A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis. Eur. Heart J. 28:1326-1333.
2. Escher, F., S. Modrow, T. Sabi, U. Kuhl, D. Lassner, H. P. Schultheiss, and M. Noutsias. 2008. Parvovirus B19 profiles in patients presenting with acute myocarditis and chronic dilated cardiomyopathy. Med. Sci. Monit. 14:CR589-CR597.
3. Frustaci, A., C. Chimenti, F. Calabrese, M. Pieroni, G. Thiene, and A. Maseri. 2003. Immunosuppressive therapy for active lymphocytic myocarditis: virological and immunologic profile of responders versus nonresponders. Circulation 107:857-863.
4. Hufnagel, G., S. Pankuweit, A. Richter, U. Schonian, and B. Maisch. 2000. The European Study of Epidemiology and Treatment of Cardiac Inflammatory Diseases (ESETCID). First epidemiological results. Herz 25:279-285.
5. + T cells after acute B19 infection. PLoS Med. 2:e343.
6. Kindermann, I., M. Kindermann, R. Kandolf, K. Klingel, B. Bultmann, T. Muller, A. Lindinger, and M. Bohm. 2008. Predictors of outcome in patients with suspected myocarditis. Circulation 118:639-648.
7. Kühl, U., D. Lassner, M. Pauschinger, U. M. Gross, B. Seeberg, M. Noutsias, W. Poller, and H. P. Schultheiss. 2008. Prevalence of erythrovirus genotypes in the myocardium of patients with dilated cardiomyopathy. J. Med. Virol. 80:1243-1251.
8. Kühl, U., M. Pauschinger, T. Bock, K. Klingel, C. P. Schwimmbeck, B. Seeberg, L. Krautwurm, M. Noutsias, W. Poller, H. P. Schultheiss, and R. Kandolf. 2003. Parvovirus B19 infection mimicking acute myocardial infarction. Circulation 108:945-950.
9. Kühl, U., M. Pauschinger, M. Noutsias, B. Seeberg, T. Bock, D. Lassner, W. Poller, R. Kandolf, and H. P. Schultheiss. 2005. High prevalence of viral genomes and multiple viral infections in the myocardium of adults with "idiopathic" left ventricular dysfunction. Circulation 111:887-893.
10. Kühl, U., M. Pauschinger, P. L. Schwimmbeck, B. Seeberg, C. Lober, M. Noutsias, W. Poller, and H. P. Schultheiss. 2003. Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction. Circulation 107:2793-2798. 4 5.
11. Kühl, U., M. Pauschinger, B. Seeberg, D. Lassner, M. Noutsias, W. Poller, and H. P. Schultheiss. 2005. Viral persistence in the myocardium is associated with progressive cardiac dysfunction. Circulation 112:1965-1970.
12. Pankuweit, S., S. Lamparter, M. Schoppet, and B. Maisch. 2004. Parvovirus B19 genome in endomyocardial biopsy specimen. Circulation 109:e179.
13. Pankuweit, S., R. Moll, U. Baandrup, I. Portig, G. Hufnagel, and B. Maisch. 2003. Prevalence of the parvovirus B19 genome in endomyocardial biopsy specimens. Hum. Pathol. 34:497-503.
14. Schenk, T., M. Enders, S. Pollak, R. Hahn, and D. Huzly. 2009. High prevalence of human parvovirus B19 DNA in myocardial autopsy samples from subjects without myocarditis or dilative cardiomyopathy. J. Clin. Microbiol. 47:106-110.
15. + T-cells with effector function and TRBV11 dominance in a patient with parvovirus B19 associated inflammatory cardiomyopathy. PLoS ONE 3:e2361.